SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a Bitcoin-native meme coin launched via the Runes protocol, is trending as the community rallies around its fair distribution and potential to drive utility on the Bitcoin network.  Many see it as a cultural movement and are actively discussing its unique position compared to other meme coins like $DOGE.X. Some community members also highlight the accumulation of $DOG.X by a publicly listed company.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as retail investors rally behind the stock, with discussions focusing on a potential gamma squeeze and speculation around a new celebrity investor possibly joining the "OPENARMY". Community members are also excited about potential upcoming catalysts like a new CEO announcement and possible interest rate cuts, contributing to the bullish sentiment. Many are debating entry strategies and expressing strong conviction in $OPEN, drawing comparisons to previous meme stock surges.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending due to positive sentiment surrounding its strong community, unique NFT collection, and potential for high returns as a meme coin on the Injective protocol. Discussions highlight its strong liquidity, active community, and the belief that it will outperform the INJ token, especially with the anticipation of a possible Injective ETF and broader altcoin season.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

$SNAP is trending as traders buzz about potential AI integration and buyout rumors, with some pointing to activity on WallStreetBets and X as a potential catalyst. Community members are actively speculating on potential acquirers and comparing valuations to competitors like Reddit. Technical analysis and short squeeze potential are also being discussed.

Injective

Injective is trending as the community focuses on its relationship with meme coin $NONJA.X, highlighting its strong community, unique art, and burned liquidity pool; some believe $NONJA.X will outperform $INJ.X. Recent news of a staked $INJ.X ETF filing with the CBOE is also generating buzz, signaling potential institutional interest in the finance-focused L1 blockchain.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid rumors of a potential acquisition by Nestle, sparking excitement and speculation within the investment community. Community members are actively discussing the possibility of a buyout offer and the potential impact on shareholder value, while also considering alternative scenarios such as partnerships and mergers. High short interest adds fuel to the discussions, with some anticipating a potential short squeeze if the rumors gain further traction.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is trending amid discussions about value perceptions and competitive strategies, with analysts weighing in on the stock's potential. The community is actively debating the impact of new menu items like snack wraps and the McCrispy strips, as well as the company's digital initiatives. Broader conversations involve consumer spending habits, pricing strategies, and the fast-food sector's overall performance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending as investors discuss the company's recent completion of a share buyback program and authorization of a new one, signaling management's confidence and potentially establishing a price floor. Community members are actively analyzing technical indicators, discussing potential price targets, and speculating on the possibility of a buyout. Bullish sentiment is building around the long-term potential of BRIUMVI and upcoming catalysts, while some express frustration with the stock's recent performance.

SSgA Active Trust - Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The Technology Select Sector SPDR Fund ($XLK) is trending amid discussions of potential market corrections, tariff implications, and sector rotation. Community members are analyzing technical indicators like death crosses and relative strength, while also weighing the impact of upcoming earnings reports from major tech companies.  Talk of potential opportunities in oversold sectors like healthcare is also circulating.

IAMGOLD Corp. engages in the exploration, development and production of gold and mineral resource properties. It owns and operates the Westwood mine in Quebec and the Cote Gold project, a development project located in Ontario. The firm also operates the Rosebel mine in Suriname, the Essakane mine in Burkina Faso, the Saramacca project, an exploration project located in Suriname, the Boto project, an exploration project located in Senegal. The company was founded by William D. Pugliese, Mark I. Nathanson, and Larry E. Phillips on March 27, 1990 and is headquartered in Toronto, Canada.

Iamgold Corp.

Iamgold Corp. is trending as community members discuss its potential for growth amid rising gold prices and increasing global uncertainty, with some suggesting it's significantly undervalued. Investors are weighing the impact of the new Cote Gold mine and potential shifts in the company's financial performance, as well as geopolitical factors such as operations in Burkina Faso. The stock is also being compared to other gold mining stocks, with discussions around potential price targets and catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results PR...

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results Accelerate Diagnostics Reports Third Quarter 2024 Financial Results PR Newswire TUCSON, Ariz., Nov. 7, 2024 TUCSON,Ariz., Nov. 7...

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc System

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc System Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc System PR Newswire TUCSON, Ariz., Sept. 30, 2024 An...

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results Accelerate Diagnostics Reports Second Quarter 2024 Financial Results PR Newswire TUCSON, Ariz., Aug. 8, 2024 TUCSON, Ariz., Aug...

Accelerate Diagnostics Announces a Successful Completion of its WAVE Pre-Clinical Trial

Accelerate Diagnostics Announces a Successful Completion of its WAVE Pre-Clinical Trial Accelerate Diagnostics Announces a Successful Completion of its WAVE Pre-Clinical Trial PR Newswire TUCSON...

Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results PR Newswire TUCSON, Ariz., Aug. 8, 2024 TUCSON...

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results PR Newswire TUCSON, Ariz., May 8, 2024...

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. PR Newswire TUCSON, Ariz., May 2, 2024 TUCSON...

Insider Selling: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) CEO Sells $13,980.56 in Stock

Accelerate Diagnostics, Inc. (NASDAQ:AXDX - Get Free Report) CEO Jack Phillips sold 15,887 shares of the company's stock in a transaction on Thursday, April 4th. The stock was sold at an average...

Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "hold" rating on...

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The firm also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.

AXDX
Accelerate Diagnostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AXDX News

AXDX Accelerate Diagnostics Inc